Catalyst

Slingshot members are tracking this event:

Amgen (AMGN) and Astellas Pharma (ALPMY) File Marketing Application in Japan for Romosozumab in Osteoporosis Patients at High Risk of Fracture

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AMGN

100%
ALPMY

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 19, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Marketing Application, Romosozumab, Osteoporosis, Fracture